Patents by Inventor QUN DU

QUN DU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMANIZED ANTI-OX40 ANTIBODIES AND USES THEREOF
    Publication number: 20180072808
    Abstract: The disclosure provides humanized anti-OX40 antibodies. Also provided are methods of making such antibodies, and methods of use, e.g., treatment of cancer.
    Type: Application
    Filed: June 28, 2017
    Publication date: March 15, 2018
    Inventors: SCOTT A. HAMMOND, MICHAEL OBERST, QUN DU, MELISSA DAMSCHRODER
  • Humanized anti-OX40 antibodies and uses thereof
    Patent number: 9738723
    Abstract: The disclosure provides humanized anti-OX40 antibodies. Also provided are methods of making such antibodies, and methods of use, e.g., treatment of cancer.
    Type: Grant
    Filed: October 7, 2015
    Date of Patent: August 22, 2017
    Assignee: MedImmune, LLC
    Inventors: Scott A. Hammond, Michael Oberst, Qun Du, Melissa Damschroder
  • BINDING MOLECULES SPECIFIC FOR IL-21 AND USES THEREOF
    Publication number: 20170173149
    Abstract: This disclosure provides IL-21 binding molecules, e.g., anti-IL-21 antibodies and antigen-binding fragments thereof. In certain aspects the anti-IL-21 antibodies and fragments thereof can be hybridoma-derived murine monoclonal antibodies, and humanized versions thereof. In certain aspects the binding molecules, e.g., anti-IL-21 antibodies and antigen-binding fragments thereof provided herein inhibit, suppress, or antagonize IL-21 activity. In addition, this disclosure provides compositions and methods for diagnosing and treating diseases or disorders, e.g., inflammatory, immune-mediated, or autoimmune diseases or disorders associated with IL-21-mediated signal transduction. In a particular embodiment, the disclosure provides methods for treating or preventing Graft-versus-host disease (GVHD) using IL-21 binding molecules, e.g., anti-IL-21 antibodies and antigen-binding fragments thereof.
    Type: Application
    Filed: April 7, 2015
    Publication date: June 22, 2017
    Inventors: Catherine Ettinger, Jodi Karnell, Melissa Damschroder, Partha Chowdhury, Xiaodong Xiao, Ping Tsui, Reena Varkey, Stacey Drabic, Laura Carter, Ronald Herbst, Qun Du, Brian Michael Naiman
  • HUMANIZED ANTI-OX40 ANTIBODIES AND USES THEREOF
    Publication number: 20160137740
    Abstract: The disclosure provides humanized anti-OX40 antibodies. Also provided are methods of making such antibodies, and methods of use, e.g., treatment of cancer.
    Type: Application
    Filed: October 7, 2015
    Publication date: May 19, 2016
    Inventors: SCOTT A. HAMMOND, MICHAEL OBERST, QUN DU, MELISSA DAMSCHRODER